Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

Abstract Introduction This post hoc analysis evaluated influenza adverse events (AEs) across rheumatoid arthritis (RA), ulcerative colitis (UC), and psoriatic arthritis (PsA) tofacitinib clinical programs. Methods Available data from phase 1, randomized phase 2/3/3b/4 clinical trials (completed by 2...

Full description

Bibliographic Details
Main Authors: Kevin L. Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal, Maria Galindo, John C. Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B. Shapiro, Thomas V. Jones, Annette Diehl, Chinyu Su, Julian Panés, Stanley B. Cohen
Format: Article
Language:English
Published: Adis, Springer Healthcare 2022-12-01
Series:Rheumatology and Therapy
Subjects:
Ulcerative colitis
Rheumatoid arthritis
Psoriatic arthritis
JAK inhibitor
Safety
Tofacitinib
Online Access:https://doi.org/10.1007/s40744-022-00507-z

Internet

https://doi.org/10.1007/s40744-022-00507-z

Similar Items